ArticleBreast cancer (Tokyo, Japan)2022

A risk scoring system based on tumor microenvironment cells to predict prognosis and immune activity in triple-negative breast cancer.

Anli Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.